<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Breast Cancer Res</journal-id><journal-title>Breast Cancer Research</journal-title><issn pub-type="ppub">1465-5411</issn><issn pub-type="epub">1465-542X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">bcr1293</article-id><article-id pub-id-type="pmid">16168130</article-id><article-id pub-id-type="doi">10.1186/bcr1293</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Changes in body weight and the risk of breast cancer in <italic>BRCA1 </italic>and <italic>BRCA2 </italic>mutation carriers</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Kotsopoulos</surname><given-names>Joanne</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>joanne.kotsopoulos@sw.ca</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Olopado</surname><given-names>Olufunmilayo I</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib id="A3" contrib-type="author"><name><surname>Ghadirian</surname><given-names>Parviz</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib id="A4" contrib-type="author"><name><surname>Lubinski</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib><contrib id="A5" contrib-type="author"><name><surname>Lynch</surname><given-names>Henry T</given-names></name><xref ref-type="aff" rid="I6">6</xref></contrib><contrib id="A6" contrib-type="author"><name><surname>Isaacs</surname><given-names>Claudine</given-names></name><xref ref-type="aff" rid="I7">7</xref></contrib><contrib id="A7" contrib-type="author"><name><surname>Weber</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="I8">8</xref></contrib><contrib id="A8" contrib-type="author"><name><surname>Kim-Sing</surname><given-names>Charmaine</given-names></name><xref ref-type="aff" rid="I9">9</xref></contrib><contrib id="A9" contrib-type="author"><name><surname>Ainsworth</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="I10">10</xref></contrib><contrib id="A10" contrib-type="author"><name><surname>Foulkes</surname><given-names>William D</given-names></name><xref ref-type="aff" rid="I11">11</xref></contrib><contrib id="A11" contrib-type="author"><name><surname>Eisen</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="I12">12</xref></contrib><contrib id="A12" contrib-type="author"><name><surname>Sun</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib id="A13" corresp="yes" contrib-type="author"><name><surname>Narod</surname><given-names>Steven A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>steven.narod@sw.ca</email></contrib></contrib-group><aff id="I1"><label>1</label>Centre for Research in Women's Health, Women's College Hospital, University of Toronto, Toronto, ON, Canada</aff><aff id="I2"><label>2</label>Department of Nutritional Sciences, University of Toronto, ON, Canada</aff><aff id="I3"><label>3</label>Center for Clinical Cancer Genetics, University of Chicago, Chicago, IL, USA</aff><aff id="I4"><label>4</label>Epidemiology Research Unit, Research Centre, Centre Hospitalier de l'Universitaire Montr&#x000e9;al, CHUM H&#x000f4;tel Dieu and D&#x000e9;partement de Nutrition, Facult&#x000e9; du M&#x000e9;decine, Quebec, QC, Canada</aff><aff id="I5"><label>5</label>Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland</aff><aff id="I6"><label>6</label>Department of Preventive Medicine and Public Health, Creighton University School of Medicine, Omaha, NE, USA</aff><aff id="I7"><label>7</label>Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, USA</aff><aff id="I8"><label>8</label>Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA</aff><aff id="I9"><label>9</label>British Columbia Cancer Agency, Vancouver, BC, Canada</aff><aff id="I10"><label>10</label>London Regional Cancer Center, London, ON, Canada</aff><aff id="I11"><label>11</label>Departments of Medicine, Human Genetics, and Oncology, McGill University, Montr&#x000e9;al, QC, Canada</aff><aff id="I12"><label>12</label>Sunnybrook and Women's College Health Sciences, Toronto, ON, Canada</aff><pub-date pub-type="ppub"><year>2005</year></pub-date><pub-date pub-type="epub"><day>19</day><month>8</month><year>2005</year></pub-date><volume>7</volume><issue>5</issue><fpage>R833</fpage><lpage>R843</lpage><ext-link ext-link-type="uri" xlink:href="http://breast-cancer-research.com/content/7/5/R833"/><history><date date-type="received"><day>10</day><month>2</month><year>2005</year></date><date date-type="rev-request"><day>31</day><month>3</month><year>2005</year></date><date date-type="rev-recd"><day>23</day><month>6</month><year>2005</year></date><date date-type="accepted"><day>6</day><month>7</month><year>2005</year></date></history><copyright-statement>Copyright &#x000a9; 2005 Kotsopoulos et al; licensee BioMed Central Ltd.</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><sec><title>Background</title><p>Several anthropometric measures have been found to be associated with the risk of breast cancer. Current weight, body mass index, and adult weight gain appear to be predictors of postmenopausal breast cancer. These factors have been associated with a reduced risk of premenopausal breast cancer. We asked whether there is an association between changes in body weight and the risk of breast cancer in women who carry a mutation in either breast cancer susceptibility gene, <italic>BRCA1 </italic>or <italic>BRCA2</italic>.</p></sec><sec sec-type="methods"><title>Methods</title><p>A matched case&#x02013;control study was conducted in 1,073 pairs of women carrying a deleterious mutation in either <italic>BRCA1 </italic>(<italic>n </italic>= 797 pairs) or <italic>BRCA2 </italic>(<italic>n </italic>= 276 pairs). Women diagnosed with breast cancer were matched to control subjects by year of birth, mutation, country of residence, and history of ovarian cancer. Information about weight was derived from a questionnaire routinely administered to women who were carriers of a mutation in either gene. Conditional logistic regression was used to estimate the association between weight gain or loss and the risk of breast cancer, stratified by age at diagnosis or menopausal status.</p></sec><sec><title>Results</title><p>A loss of at least 10 pounds in the period from age 18 to 30 years was associated with a decreased risk of breast cancer between age 30 and 49 (odds ratio (OR) = 0.47; 95% confidence interval (CI) 0.28&#x02013;0.79); weight gain during the same interval did not influence the overall risk. Among the subgroup of <italic>BRCA1 </italic>mutation carriers who had at least two children, weight gain of more than 10 pounds between age 18 and 30 was associated with an increased risk of breast cancer diagnosed between age 30 and 40 (OR = 1.44, 95% CI 1.01&#x02013;2.04). Change in body weight later in life (at age 30 to 40) did not influence the risk of either premenopausal or postmenopausal breast cancer.</p></sec><sec><title>Conclusion</title><p>The results from this study suggest that weight loss in early adult life (age 18 to 30) protects against early-onset <italic>BRCA-</italic>associated breast cancers. Weight gain should also be avoided, particularly among <italic>BRCA1 </italic>mutation carriers who elect to have at least two pregnancies.</p></sec></abstract></article-meta></front><body><sec><title>Introduction</title><p>The inheritance of a deleterious mutation in either of the two breast cancer susceptibility genes, <italic>BRCA1 </italic>or <italic>BRCA2</italic>, has been associated with a lifetime risk of breast cancer of 45% to 87% [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Reports of increasing penetrance among women born in recent cohorts in comparison with those born in earlier years has prompted the search for factors that may influence the risk of cancer in genetically susceptible women [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. To date, both genetic and non-genetic factors have been suggested to influence breast cancer risk in <italic>BRCA1 </italic>and <italic>BRCA2 </italic>mutation carriers, and many implicate estrogen-induced stimulation as a probable contributor (reviewed in [<xref ref-type="bibr" rid="B6">6</xref>]). Genetic risk factors include both the type and position of the mutation [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>], as well as the presence of specific alleles of modifying genes [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. Non-genetic or environmental factors include hormonal factors, in particular those related to estrogen exposure (reviewed in [<xref ref-type="bibr" rid="B6">6</xref>]). Reproductive factors that modify risk in <italic>BRCA</italic> carriers include breastfeeding, parity, and oral contraceptive use (reviewed in [<xref ref-type="bibr" rid="B14">14</xref>]).</p><p>The worldwide prevalence of obesity is rising [<xref ref-type="bibr" rid="B15">15</xref>]. Evidence from animal studies suggests that positive energy balance has a growth-promoting effect on tumours [<xref ref-type="bibr" rid="B16">16</xref>]. Numerous epidemiological studies have evaluated the role of various anthropometric risk factors in the etiology of breast cancer (reviewed in [<xref ref-type="bibr" rid="B17">17</xref>]). Collectively, the evidence suggests that the effects of body mass index (BMI) and of adult weight gain on the risk of breast cancer are dependent on menopausal status at diagnosis. There appears to be an inverse relation between both BMI and weight and the risk of premenopausal breast cancer; whereas there is a positive association between body weight, BMI, and adult weight gain on the risk of breast cancer after the menopause (reviewed in [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B20">20</xref>]). Birthweight and adult height have been associated with an increased risk of breast cancer in both menopausal strata (reviewed in [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B20">20</xref>]). Weight change that occurs at the time a woman is undergoing hormonal changes (i.e. puberty, pregnancy, menopause) has also been suggested to have an effect on risk [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Although various biological mechanisms by which weight may influence breast cancer risk have been proposed (reviewed in [<xref ref-type="bibr" rid="B17">17</xref>]), of particular relevance is an increase in circulating endogenous sex hormones, particularly estrogen [<xref ref-type="bibr" rid="B23">23</xref>]. Epidemiologic observations and laboratory studies suggest that sex hormones play an important role in <italic>BRCA</italic>-carcinogenesis and the current chemopreventive options available for <italic>BRCA </italic>carriers are based on the interruption of the estrogen-signalling pathway (reviewed in [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B24">24</xref>]).</p><p>Studies are needed to determine if the known anthropometric risk factors for sporadic breast cancer may also influence the penetrance of breast cancer in <italic>BRCA </italic>carriers. We performed a matched case&#x02013;control study to investigate whether or not there is an association between changes in body weight and the risk of breast cancer in women with a deleterious <italic>BRCA1 </italic>or <italic>BRCA2 </italic>mutation. The identification of non-genetic modifiers of risk may be useful for preventing hereditary breast cancer.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Study population and design</title><p>Eligible study subjects included women who were alive and known to be carriers of deleterious mutations of the <italic>BRCA1 </italic>or <italic>BRCA2 </italic>gene. These women were identified from 41 participating centers in five countries and were participants in previous and ongoing clinical research protocols at the host institutions. All study subjects received counselling and gave their written informed consent for genetic testing.</p><p>The study was approved by the institutional review boards of the host institutions. In most cases, testing was initially offered to women who had been affected with breast or ovarian cancer. When a <italic>BRCA1 </italic>or <italic>BRCA2 </italic>mutation was identified in a proband or her relative, genetic testing was offered to other at-risk women in the family. Mutation detection was performed using a range of techniques, but all nucleotide sequences were confirmed by direct sequencing of DNA. A woman was eligible for the current study when the molecular analysis established that she was a carrier of a pathogenic mutation. Most (&#x0003e;95%) of the mutations identified in the study subjects were nonsense mutations, deletions, insertions, or small frameshifts.</p><p>There was information on cancer history and mutation carrier status for a total of 3,291 women who carried <italic>BRCA1 </italic>or <italic>BRCA2 </italic>mutations and who provided information on weight at ages 18, 30, and 40. Potential case subjects were selected from among the study subjects with a diagnosis of invasive breast cancer. Case subjects were excluded if they had been diagnosed with ovarian cancer (29 women) or any other form of cancer (28 women) before being diagnosed with breast cancer, or if information about their menopausal status was missing (31 women). Control subjects were women who had never had breast cancer and who were carriers of a mutation in the <italic>BRCA1 </italic>or <italic>BRCA2 </italic>gene. A subject was not eligible to be a control for a given case subject if she had had a protective bilateral mastectomy before the date of diagnosis in the case (88 women). After exclusions, there was a total of 3,115 eligible women, including 1,471 women with breast cancer (potential case subjects) and 1,644 women without breast cancer (potential controls).</p><p>A single control subject was selected for each case subject, matched according to mutation in the same gene (<italic>BRCA1 </italic>or <italic>BRCA2</italic>), year of birth (within 1 year), and the country of residence. A diagnosis of ovarian or other form of cancer in the control had to be after the year of diagnosis of breast cancer of the matched case subject for her to be eligible. In addition, the date of interview of the control was after the date of breast cancer diagnosis of the matched case. A total of 1,073 matched case&#x02013;control pairs was generated for the analysis, including 797 pairs with <italic>BRCA1 </italic>mutations and 276 pairs with <italic>BRCA2 </italic>mutations. The 2,146 study subjects included in the analysis were identified from 1,534 distinct families (1.4 subjects per family). In the instance of 1,179 subjects, the subject was the only member of the family to be included. These were prevalent cases and had breast cancer before they knew their mutation status. On average, 8.8 years had passed between the subject's age at diagnosis (mean 39.8 years) and age at interview (mean 48.6 years).</p></sec><sec><title>Data collection</title><p>Case and control subjects completed a questionnaire that asked for relevant information regarding family history, reproductive and medical histories, and selected lifestyle factors including smoking history and use of oral contraceptives. Questionnaires were administered by each of the individual centers at the time of a clinic appointment or at their home at a later date. Interviews occurred between 1988 and 2004 for the case subjects and between 1994 and 2004 for the control subjects. Additional variables of interest included information on demography, ethnicity, and parity. Women were classified as postmenopausal if they reported natural menopause and had stopped menstruating, or if they had had a hysterectomy and bilateral oophorectomy before the diagnosis of breast cancer. Specifically for this study, the questionnaire asked for information on height (in feet and inches) and weight (in pounds). The participants were requested to think back to when they were 18 years old (about the time they graduated from high school) and to recall their weight then and subsequently at ages 30 and 40. Women were asked to report their weight at birth, their current weight, and their height, as well as the most they had ever weighed (excluding pregnancy). Only case and control data before the time of the diagnosis of breast cancer in the matched case were considered.</p></sec><sec><title>Anthropometric measures</title><p>We converted the reported weights from pounds to kilograms and the heights from inches to meters for BMI calculations. Variables that were created in this study included BMI (weight (kg)/height(m<sup>2</sup>)) at ages 18, 30, and 40 years, and weight change between age 18 and 30 and between 30 and 40 (calculated as the difference between the weights at the age periods being compared).</p></sec><sec><title>Statistical analyses</title><p>A matched case &#x02013; control analysis was performed to examine the association between weight and changes in body weight, and the risk of breast cancer. Because menopausal status has been shown to modify the association between anthropometric factors and the risk of breast cancer, our analyses were stratified according to menopausal status at the time the subject received a diagnosis of breast cancer diagnosis. Birthweight, height, weight, weight gain, and BMI were compared between the case subjects and control subjects within each stratum, using a paired <italic>t</italic>-test. This test statistic was also used for all other continuous variables that were examined. The &#x003c7;<sup>2 </sup>test was used to test for differences in categorical variables. The univariate odds ratios (ORs), 95% confidence intervals (CIs), and tests for linear trend were estimated by use of conditional logistic regression. A multivariate analysis was also carried out to control for the potential confounding effects of oral contraceptive use, smoking, oophorectomy, and parity. Smoking use was coded as 'ever' or 'never' smoker; oral contraceptive use was coded as 'ever' or 'never' user; oophorectomy was coded as yes or no; and parity was coded as zero, one, or two or more births. Weight change was categorized into quartiles according to the distribution of the variables among the controls.</p><p>The reference group were those women whose weight remained stable (weight gain or loss of not more than 10 pounds from baseline). The weight-loss group included women who lost at least 10 pounds. We examined the effect of weight change between ages 18 and 30 and between ages 30 and 40 among subgroups defined according to the subject's age at diagnosis of the case. This effect was further evaluated according to mutation and menopausal status. There were 26 menopausal case subjects who reported having had a hysterectomy before their breast cancer had been diagnosed but who still had intact ovaries. These 26 pairs were excluded from the subanalyses stratified by menopausal status. Odds ratios were generated for these subgroups with the matched-pair subsets. All statistical tests were two-sided. A <italic>P </italic>value of &#x0003c;0.05 was taken to be significant. All analyses were performed using the SAS statistical package, version 8.1 (SAS Institute, Cary, NC, USA).</p></sec></sec><sec><title>Results</title><sec><title>Study subjects</title><p>Case and control subjects were similar with regard to year of birth, year of interview, current age, mutation status, smoking history, and country of residence (Table <xref ref-type="table" rid="T1">1</xref>). Oral contraceptives had been used by more of the case than control subjects (<italic>P </italic>= 0.04), and parity was also slightly higher in the case than control subjects (<italic>P </italic>= 0.06).</p></sec><sec><title>Comparison of anthropometric measures in <italic>BRCA1 </italic>or <italic>BRCA2 </italic>mutation carriers</title><p>Table <xref ref-type="table" rid="T2">2</xref> compares the mean values for various anthropometric measures for the cases and controls as a whole, and stratified by the menopausal status of the case subject when the breast cancer was diagnosed. Among all the study participants, case subjects weighed less at age 18 than the control subjects. Among postmenopausal women, case subjects had a lower BMI at age 18 than controls. There were no other statistically significant differences between the case and control subjects with respect to weight at birth, current height, weight, BMI, or weight gain at various ages (Table <xref ref-type="table" rid="T2">2</xref>).</p><p>The extent of weight gain experienced by our study subjects varied according to their year of birth (Fig. <xref ref-type="fig" rid="F1">1</xref>). Those born in earlier years experienced on average less weight gain between age 18 and 30 and between 18 and 40 than women born in later years. The increase in weight by calendar year is most apparent at the ages of 30 and 40. There was also a significant difference between the mean weights at ages 18, 30, and 40 among women residing in Canada, Poland, or the USA (<italic>P </italic>= 0.0001, 0.02, and 0.02, respectively).</p></sec><sec><title>Changes in body weight between age 18 and 30 and risk of breast cancer in <italic>BRCA </italic>mutation carriers</title><p>To further examine the relationship between adult weight change and the risk of breast cancer, we performed univariate conditional logistic regression. The adjusted ORs were similar to the unadjusted values; therefore, only univariate results are reported here. As Table <xref ref-type="table" rid="T3">3</xref> shows, weight loss of at least 10 pounds between age 18 and 30 was associated with a significant reduction in breast cancer risk thereafter (OR = 0.66). Weight gain during this period was not associated with increased risk. However, stratification of the study subjects according to their age at breast cancer diagnosis indicated that changes in body weight appeared to have different effects in carriers according to whether the breast cancer was diagnosed before or after age 40. Weight loss of at least 10 pounds was associated with a significant reduction in the risk of breast cancer diagnosed between age 30 and 40 (OR = 0.47) (Table <xref ref-type="table" rid="T3">3</xref>) but was not associated with the risk of breast cancer diagnosed after age 40.</p><p>Subgroup analyses according to <italic>BRCA </italic>mutation status showed that among women with a <italic>BRCA1 </italic>mutation, weight loss of at least 10 pounds was associated with a 65% reduction in cancer risk compared with women in the reference group (OR = 0.35) (Table <xref ref-type="table" rid="T4">4</xref>). A modest protective effect of this degree of weight loss was also seen among <italic>BRCA2 </italic>mutation carriers, although this association did not reach statistical significance (OR = 0.88).</p><p>The mean baseline weight (weight at age 18) of the <italic>BRCA1 </italic>mutation carriers who lost more than 10 pounds was 142.5 pounds (range 115 to 230 pounds). These women experienced a mean weight loss of 18.6 pounds (range 10 to 86 pounds) between age 18 and 30. Forty percent of these women had a mean baseline weight greater than 150 pounds and 35% had a BMI greater than 25.</p></sec><sec><title>Changes in body weight between age 18 and 30, parity, and risk of breast cancer in <italic>BRCA </italic>mutation carriers</title><p>Because parity has been shown to modify the risk of breast cancer in carriers [<xref ref-type="bibr" rid="B25">25</xref>], we next examined the risk of breast cancer associated with weight gain but taking into account the possible modifying effect of parity (Table <xref ref-type="table" rid="T5">5</xref>). Compared with those who experienced minimal changes in body weight (&#x000b1; 10 pounds), weight gain of greater than 10 pounds among women who had at least two full-term pregnancies was significantly associated with an increase in the risk of breast cancer (OR = 1.44). To discern whether increased parity <italic>per se</italic> was associated with weight gain, we compared mean weight gain among the carriers, according to parity. The mean weight gain across the groups was similar (data not shown). Therefore, the increased risk of breast cancer associated with parity and any weight gain is not attributable to greater weight gain among those who had higher parity. A modifying effect of parity and weight gain was not seen among women with a <italic>BRCA2 </italic>mutation (Table <xref ref-type="table" rid="T5">5</xref>).</p></sec></sec><sec><title>Discussion</title><p>We conducted our study to examine whether change in body weight modifies the risk of breast cancer among women who carry a deleterious <italic>BRCA1 </italic>or <italic>BRCA2 </italic>mutation. We found that <italic>BRCA </italic>mutation carriers who lost at least 10 pounds between age 18 and 30 had a 34% reduction in the risk of breast cancer. However, on stratification of the sample by age of breast cancer diagnosis, this protective effect was only observed among <italic>BRCA </italic>mutation carriers diagnosed between age 30 and 40 and not for those diagnosed after age 40. Although weight loss reduced the risk of breast cancer among carriers of either mutation, this association remained significant only for women with a <italic>BRCA1 </italic>mutation (OR = 0.35). A large proportion of the group who experienced weight loss had a baseline BMI of greater than 25, the BMI cut-point for the classification of overweight individuals [<xref ref-type="bibr" rid="B26">26</xref>]. This suggests that recommendations regarding weight loss should be targeted towards those women who are considered to be overweight at age 18.</p><p>The role of early adult weight gain and subsequent risk of breast cancer is not well defined. The majority of studies report either no association or a decrease in risk with weight gain for premenopausal women, and inconsistent results for postmenopausal women [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. It has been suggested that adult weight gain may be a better measure of adiposity than BMI, because lean body mass decreases with age [<xref ref-type="bibr" rid="B27">27</xref>] and BMI does not distinguish between lean and fat mass; whereas changes in adult weight largely reflect changes in body fat [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Adult weight gain appears to be a consistent and independent predictor of postmenopausal breast cancer risk, particularly in women who never used hormone replacement therapy [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B31">31</xref>]. Studies of adult weight gain and the risk of premenopausal breast cancer have generally shown a reduction in risk, although two studies found no association [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. In our selected study population as a whole, weight gain did not influence risk. Rather, we observed a decrease in the risk of breast cancer diagnosed between age 31 and 40 associated with weight loss in early adulthood (between age 18 and 30). Weight change that occurred between age 30 and 40 did not influence the subsequent risk of either premenopausal or postmenopausal breast cancer. Our findings suggest an important effect of weight loss in early years and the risk of early-onset breast cancer. This effect is of particular relevance to our study population, because a characteristic feature of <italic>BRCA</italic>-associated breast cancers is young age at diagnosis [<xref ref-type="bibr" rid="B33">33</xref>].</p><p>Our findings suggest that in <italic>BRCA </italic>carriers, changes in body weight throughout early adult life may have a more important influence on the risk of early-onset breast cancer than current weight or BMI [<xref ref-type="bibr" rid="B21">21</xref>]. The magnitude of the decreased risk associated with weight loss compared with those women whose weight remained stable was relatively large (OR = 0.47) (see Table <xref ref-type="table" rid="T3">3</xref>). After stratification by mutation status, the protective effect of weight loss between age 18 and 30 was seen to be less strong among women with a <italic>BRCA2 </italic>mutation. These findings suggest that the timing of weight loss may play a more important role in <italic>BRCA1</italic>-associated than in <italic>BRCA2</italic>-associated carcinogenesis, though the lack of a significant finding for the latter group might also be attributable to a smaller sample size. The effect may be of greater importance for women belonging to more recent birth cohorts, since there appears to be a greater increase in average weight at ages 30 and 40 with each decade (see Fig. <xref ref-type="fig" rid="F1">1</xref>).</p><p>We also found that in the subgroup of <italic>BRCA1 </italic>mutation carriers who gained 10 pounds or more and who had at least two full-term pregnancies, there was a 44% increase in their risk of breast cancer. The modifying effects of both parity and weight gain were not observed for women with a <italic>BRCA2 </italic>mutation. The number of births did not influence the amount of weight gain experienced by either the case or the control subjects, providing confirmation that weight gain is not a surrogate for parity or vice versa. Although pregnancy itself offers long-term protection against postmenopausal breast cancer in the general population, significant weight gain during pregnancy has been associated with an increased risk of developing breast cancer after the menopause [<xref ref-type="bibr" rid="B34">34</xref>]. We have reported elsewhere that parity is a risk factor for breast cancer in <italic>BRCA2 </italic>carriers but not in <italic>BRCA1 </italic>carriers [<xref ref-type="bibr" rid="B25">25</xref>].</p><p>Ballard-Barbash proposed that weight change that occurs during periods of noticeable hormonal change (i.e. menarche, pregnancy, and menopause) may be attributed to host metabolic factors that may also influence breast cancer risk [<xref ref-type="bibr" rid="B21">21</xref>]. In addition, weight gain may result in differing biological effects depending on the body fat distribution [<xref ref-type="bibr" rid="B21">21</xref>]. Weight gain during pregnancy is characterized by an increase in central body fat deposition [<xref ref-type="bibr" rid="B35">35</xref>]. The physiological consequences of upper or central body fat localization include altered ovarian hormone and glucose metabolism, as well as insulin resistance and hyperinsulinemia, all of which may increase breast cancer risk [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. This pattern of fat distribution has been suggested to pose a higher risk of breast cancer, independent of weight [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B37">37</xref>].</p><p>Only two studies have evaluated the association between anthropometric risk factors or physical activity and the risk of breast cancer in <italic>BRCA1 </italic>and/or <italic>BRCA2 </italic>carriers [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. King and colleagues recently reported that a healthy weight defined at menarche and at age 21, as well as physical activity during adolescence, were associated with a significant delay in the age of onset of breast cancer in <italic>BRCA1 </italic>and <italic>BRCA2 </italic>carriers; however, such an effect could be attributable to either weight gain increasing the risk of early-onset breast cancer or to weight gain protecting against late-onset breast cancer [<xref ref-type="bibr" rid="B4">4</xref>]. An earlier study of 46 <italic>BRCA1 </italic>carriers found no significant effect of current BMI on the age at disease onset; however, the sample size was small [<xref ref-type="bibr" rid="B38">38</xref>].</p><p>The role of sex hormones in the etiology of breast cancer has been well established [<xref ref-type="bibr" rid="B23">23</xref>]. It is generally agreed that increasing levels of circulating estrogen are a determinant of obesity-associated breast cancer in postmenopausal women [<xref ref-type="bibr" rid="B39">39</xref>]. In contrast, most investigations of premenopausal women report an inverse association between weight (or BMI or weight gain) and the risk of breast cancer. The epidemiological evidence suggests a positive association between these anthropometric variables and the risk of postmenopausal breast cancer (reviewed in [<xref ref-type="bibr" rid="B17">17</xref>]). The primary hypothesis underlying this relation between menopausal status and the risk of breast cancer is believed to involve an alteration in the source and levels of endogenous sex hormones [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. Before menopause, the ovaries are the primary site of endogenous hormone production. Since obesity has been shown to induce chronic anovulatory cycles and subsequently lower serum estrogen [<xref ref-type="bibr" rid="B41">41</xref>] and progesterone levels [<xref ref-type="bibr" rid="B42">42</xref>], a decrease in hormone exposure is believed to be the primary mechanism by which overweight women may be protected against premenopausal breast cancer [<xref ref-type="bibr" rid="B43">43</xref>]. Extraglandular aromatization of androstenedione to estrone occurs in the adipose tissue and is the primary source of estradiol in postmenopausal women [<xref ref-type="bibr" rid="B39">39</xref>]. This conversion of androgens and subsequent increase in estrogen levels has been shown to be directly proportional to the amount of adipose tissue [<xref ref-type="bibr" rid="B44">44</xref>] and the induction of aromatase activity which may possibly enhance estrogen production in adipose tissue [<xref ref-type="bibr" rid="B45">45</xref>]. In contrast, among <italic>BRCA </italic>carriers, weight gain did not affect the risk of breast cancer.</p><p>Other metabolic consequences of obesity, more specifically central adiposity, that have been suggested to be factors in the development of breast cancer include hyperinsulinemia and insulin resistance, as well as elevated levels of glucose and triglycerides [<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B50">50</xref>]. Obesity has also been shown to increase testosterone [<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B52">52</xref>] and leptin levels, [<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B54">54</xref>] and to depress sex-hormone-binding globulin concentrations. This globulin is the predominant carrier of estradiol levels in both premenopausal and postmenopausal women and is the primary protein responsible for binding and inactivating estradiol [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B56">56</xref>]. Therefore, reducing the concentration of sex-hormone-binding globulin may lead to an increase in the amount of unbound, free estradiol.</p><p>High concentrations of circulating insulin-like growth factor1 (IGF-1) appears to be a risk factor for premenopausal breast cancer in the general population, yet no such relation has been observed for postmenopausal breast cancer [<xref ref-type="bibr" rid="B57">57</xref>]. Studies have shown that both insulin and IGF-1 exert a mitogenic effect by stimulating cell proliferation and inhibiting apoptosis of breast cancer cells [<xref ref-type="bibr" rid="B58">58</xref>,<xref ref-type="bibr" rid="B59">59</xref>]. More importantly, it has been suggested that IGF-1 may also work synergistically with other growth factors and hormones, including estrogen, to further promote cell proliferation [<xref ref-type="bibr" rid="B60">60</xref>]. Although both BMI and IGF-1 levels are suggested to influence breast cancer risk, studies have generally shown no association or an inverse association between BMI and circulating IGF-1 levels [<xref ref-type="bibr" rid="B60">60</xref>].</p><p>Both birthweight [<xref ref-type="bibr" rid="B61">61</xref>,<xref ref-type="bibr" rid="B62">62</xref>] and height [<xref ref-type="bibr" rid="B63">63</xref>] are positively associated with IGF-1 levels. The evidence, primarily from cohort studies, supports a positive association between birthweight and the risk of breast cancer (reviewed in [<xref ref-type="bibr" rid="B64">64</xref>]) suggesting that prenatal events may influence later risk. Adult height has also been shown to positively predict the risk of breast cancer in both pre- and postmenopausal women [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. In our study, there was no significant difference in birthweight between the cases and controls and it seems unlikely that this variable influences risk in <italic>BRCA </italic>mutation carriers. Current height was not associated with the risk of breast cancer, and this observation is in agreement with a pooled analysis of 52 epidemiological studies whereas height did not modify risk in women who had one or more affected first-degree relatives in comparison with women who had no affected relatives [<xref ref-type="bibr" rid="B65">65</xref>].</p><p>A potential drawback of our study was the use of self-reported risk factor data, which may have introduced measurement error and led to a spurious result or attenuation of results. However, validation studies have shown that current and recalled self-reported weight and height measurements are highly correlated with measured data [<xref ref-type="bibr" rid="B66">66</xref>-<xref ref-type="bibr" rid="B72">72</xref>]. Self-reporting many years prior has still been shown to retain a high degree of validity [<xref ref-type="bibr" rid="B19">19</xref>]. Our data was collected on average 9 years after the breast cancer diagnosis of the case, and 30 years after age 18 (the first weight reported). There is a potential for recall bias but there is no evidence of this in Table <xref ref-type="table" rid="T2">2</xref>. The mean weights at each reported age were similar and the differences were not significant. In fact, the reported weight at age 18 was less for cases than controls (we might expect recall bias to generate the opposite result). Also, the dissimilar results for <italic>BRCA1 </italic>and <italic>BRCA2 </italic>carriers argues against recall bias.</p><p>Despite the primary limitation of recall bias and other inherent limitations associated with the use of case&#x02013;control studies, the primary strength of our study is the large sample of known <italic>BRCA </italic>mutation carriers. This study involved 1,073 matched pairs selected from a total of approximately 3,291 documented mutation carriers and is by far the largest study addressing the role of anthropometric measures on the risk of hereditary breast cancer. Our matching strategy and exclusion criteria resulted in case and control groups that were similar in most respects. We believe that our study participants are representative of women who have had <italic>BRCA </italic>mutations identified during the course of genetic counselling. Our study was based on known mutation carriers and included patients from numerous participating centers and of different ethnic backgrounds.</p></sec><sec><title>Conclusion</title><p>Our findings suggest that weight loss in early adult life (and not weight <italic>per se</italic>) decreases the risk of <italic>BRCA</italic>-associated breast cancer diagnosed at an early age. More specifically, the period between age 18 and 30 years appears to be a critical one when weight gain should be avoided in mutation carriers. The effect may be greatest in <italic>BRCA1 </italic>carriers experiencing at least two full-term pregnancies, but further study is necessary to confirm this subgroup analysis. The maintenance of a healthy weight during early adult life represents a potentially modifiable risk factor in hereditary breast cancer syndromes.</p></sec><sec><title>Abbreviations</title><p><italic>BRCA1 </italic>= breast cancer susceptibility gene 1; <italic>BRCA2 </italic>= breast cancer susceptibility gene 2; CI = confidence interval; IGF-1 = insulin-like growth factor 1<bold>; </bold>OR = odds ratio.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>SAN conceived and designed the study. JK drafted the manuscript and helped with the analysis. PS performed the statistical analysis. OIO, PG, JL, HTL, CI, BW, CK-S, PA, WDF, and AI coordinated study activities for their centers and helped with the preparation of the manuscript. All authors read and approved the final version of the manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank B Rosen, S Randall, M Daly, N Tung, H Saal, E Friedman, B Karlan, E Warner, M Osborne, D Fishman, C Eng, M Wood, W McKinnon, S Merajver, D Gilchrist, J Weitzel, G Evans, D Provencher, A Chudley, E Lemire, and J McLennan for submission of data on their patients.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>D</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Stratton</surname><given-names>M</given-names></name><name><surname>Narod</surname><given-names>S</given-names></name><name><surname>Goldar</surname><given-names>D</given-names></name><name><surname>Devilee</surname><given-names>P</given-names></name><name><surname>Bishop</surname><given-names>DT</given-names></name><name><surname>Weber</surname><given-names>B</given-names></name><name><surname>Lenoir</surname><given-names>G</given-names></name><name><surname>Chang-Claude</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium</article-title><source>Am J Hum Genet</source><year>1998</year><volume>62</volume><fpage>676</fpage><lpage>689</lpage><pub-id pub-id-type="pmid">9497246</pub-id><pub-id pub-id-type="doi">10.1086/301749</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antoniou</surname><given-names>A</given-names></name><name><surname>Pharoah</surname><given-names>PD</given-names></name><name><surname>Narod</surname><given-names>S</given-names></name><name><surname>Risch</surname><given-names>HA</given-names></name><name><surname>Eyfjord</surname><given-names>JE</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name><name><surname>Loman</surname><given-names>N</given-names></name><name><surname>Olsson</surname><given-names>H</given-names></name><name><surname>Johansson</surname><given-names>O</given-names></name><name><surname>Borg</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies</article-title><source>Am J Hum Genet</source><year>2003</year><volume>72</volume><fpage>1117</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">12677558</pub-id><pub-id pub-id-type="doi">10.1086/375033</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narod</surname><given-names>S</given-names></name><name><surname>Lynch</surname><given-names>H</given-names></name><name><surname>Conway</surname><given-names>T</given-names></name><name><surname>Watson</surname><given-names>P</given-names></name><name><surname>Feunteun</surname><given-names>J</given-names></name><name><surname>Lenoir</surname><given-names>G</given-names></name></person-group><article-title>Increasing incidence of breast cancer in family with BRCA1 mutation</article-title><source>Lancet</source><year>1993</year><volume>341</volume><fpage>1101</fpage><lpage>1102</lpage><pub-id pub-id-type="pmid">8097005</pub-id><pub-id pub-id-type="doi">10.1016/0140-6736(93)92468-9</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>MC</given-names></name><name><surname>Marks</surname><given-names>JH</given-names></name><name><surname>Mandell</surname><given-names>JB</given-names></name></person-group><article-title>Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>643</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">14576434</pub-id><pub-id pub-id-type="doi">10.1126/science.1088759</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foulkes</surname><given-names>WD</given-names></name><name><surname>Brunet</surname><given-names>JS</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>Goffin</surname><given-names>J</given-names></name><name><surname>Chappuis</surname><given-names>PO</given-names></name></person-group><article-title>Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study</article-title><source>J Med Genet</source><year>2002</year><volume>39</volume><fpage>407</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">12070248</pub-id><pub-id pub-id-type="doi">10.1136/jmg.39.6.407</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narod</surname><given-names>SA</given-names></name></person-group><article-title>Modifiers of risk of hereditary breast and ovarian cancer</article-title><source>Nat Rev Cancer</source><year>2002</year><volume>2</volume><fpage>113</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">12635174</pub-id><pub-id pub-id-type="doi">10.1038/nrc726</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gayther</surname><given-names>SA</given-names></name><name><surname>Warren</surname><given-names>W</given-names></name><name><surname>Mazoyer</surname><given-names>S</given-names></name><name><surname>Russell</surname><given-names>PA</given-names></name><name><surname>Harrington</surname><given-names>PA</given-names></name><name><surname>Chiano</surname><given-names>M</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><name><surname>Hamoudi</surname><given-names>R</given-names></name><name><surname>van Rensburg</surname><given-names>EJ</given-names></name><etal></etal></person-group><article-title>Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation</article-title><source>Nat Genet</source><year>1995</year><volume>11</volume><fpage>428</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">7493024</pub-id><pub-id pub-id-type="doi">10.1038/ng1295-428</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gayther</surname><given-names>SA</given-names></name><name><surname>Mangion</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>P</given-names></name><name><surname>Seal</surname><given-names>S</given-names></name><name><surname>Barfoot</surname><given-names>R</given-names></name><name><surname>Ponder</surname><given-names>BA</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Easton</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene</article-title><source>Nat Genet</source><year>1997</year><volume>15</volume><fpage>103</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">8988179</pub-id><pub-id pub-id-type="doi">10.1038/ng0197-103</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>D</given-names></name><name><surname>Easton</surname><given-names>D</given-names></name></person-group><article-title>Variation in cancer risks, by mutation position, in BRCA2 mutation carriers</article-title><source>Am J Hum Genet</source><year>2001</year><volume>68</volume><fpage>410</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">11170890</pub-id><pub-id pub-id-type="doi">10.1086/318181</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rebbeck</surname><given-names>TR</given-names></name><name><surname>Kantoff</surname><given-names>PW</given-names></name><name><surname>Krithivas</surname><given-names>K</given-names></name><name><surname>Neuhausen</surname><given-names>S</given-names></name><name><surname>Blackwood</surname><given-names>MA</given-names></name><name><surname>Godwin</surname><given-names>AK</given-names></name><name><surname>Daly</surname><given-names>MB</given-names></name><name><surname>Naraod</surname><given-names>SA</given-names></name><name><surname>Garber</surname><given-names>JE</given-names></name><name><surname>Lynch</surname><given-names>HT</given-names></name><etal></etal></person-group><article-title>Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat</article-title><source>Am J Hum Genet</source><year>1999</year><volume>64</volume><fpage>1371</fpage><lpage>1377</lpage><pub-id pub-id-type="pmid">10205268</pub-id><pub-id pub-id-type="doi">10.1086/302366</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rebbeck</surname><given-names>TR</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kantoff</surname><given-names>PW</given-names></name><name><surname>Krithivas</surname><given-names>K</given-names></name><name><surname>Neuhausen</surname><given-names>SL</given-names></name><name><surname>Godwin</surname><given-names>AK</given-names></name><name><surname>Daly</surname><given-names>MB</given-names></name><name><surname>Narod</surname><given-names>SA</given-names></name><name><surname>Brunet</surname><given-names>JS</given-names></name><name><surname>Vesprini</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>5420</fpage><lpage>5424</lpage><pub-id pub-id-type="pmid">11454686</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>WW</given-names></name><name><surname>Spurdle</surname><given-names>AB</given-names></name><name><surname>Kolachana</surname><given-names>P</given-names></name><name><surname>Bove</surname><given-names>B</given-names></name><name><surname>Moden</surname><given-names>B</given-names></name><name><surname>Ebbers</surname><given-names>SM</given-names></name><name><surname>Suthers</surname><given-names>G</given-names></name><name><surname>Tucker</surname><given-names>MA</given-names></name><name><surname>Kaufman</surname><given-names>DJ</given-names></name><name><surname>Doody</surname><given-names>MM</given-names></name><etal></etal></person-group><article-title>A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2001</year><volume>10</volume><fpage>955</fpage><lpage>960</lpage><pub-id pub-id-type="pmid">11535547</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levy-Lahad</surname><given-names>E</given-names></name><name><surname>Lahad</surname><given-names>A</given-names></name><name><surname>Eisenberg</surname><given-names>S</given-names></name><name><surname>Dagan</surname><given-names>E</given-names></name><name><surname>Paperna</surname><given-names>T</given-names></name><name><surname>Kasinetz</surname><given-names>L</given-names></name><name><surname>Catane</surname><given-names>R</given-names></name><name><surname>Kaufman</surname><given-names>B</given-names></name><name><surname>Beller</surname><given-names>U</given-names></name><name><surname>Renbaum</surname><given-names>B</given-names></name><etal></etal></person-group><article-title>A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>3232</fpage><lpage>3236</lpage><pub-id pub-id-type="pmid">11248061</pub-id><pub-id pub-id-type="doi">10.1073/pnas.051624098</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narod</surname><given-names>SA</given-names></name><name><surname>Offit</surname><given-names>K</given-names></name></person-group><article-title>Prevention and management of hereditary breast cancer</article-title><source>J Clin Oncol</source><year>2005</year><volume>23</volume><fpage>1656</fpage><lpage>1663</lpage><pub-id pub-id-type="pmid">15755973</pub-id><pub-id pub-id-type="doi">10.1200/JCO.2005.10.035</pub-id></citation></ref><ref id="B15"><citation citation-type="other"><article-title>International Obesity Task Force</article-title><ext-link ext-link-type="uri" xlink:href="http://www.iotf.org/"/></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tannenbaum</surname><given-names>A</given-names></name></person-group><article-title>The dependence of tumor formation on the composition of the calorie-restricted diet as well as on the degree of restriction. 1945</article-title><source>Nutrition</source><year>1996</year><volume>12</volume><fpage>653</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">8878181</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedenreich</surname><given-names>CM</given-names></name></person-group><article-title>Review of anthropometric factors and breast cancer risk</article-title><source>Eur J Cancer Prev</source><year>2001</year><volume>10</volume><fpage>15</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11263588</pub-id><pub-id pub-id-type="doi">10.1097/00008469-200102000-00003</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van den Brandt</surname><given-names>PA</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Yaun</surname><given-names>SS</given-names></name><name><surname>Adami</surname><given-names>HO</given-names></name><name><surname>Beeson</surname><given-names>L</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Fraser</surname><given-names>G</given-names></name><name><surname>Goldbohm</surname><given-names>RA</given-names></name><name><surname>Graham</surname><given-names>S</given-names></name><name><surname>Kushi</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk</article-title><source>Am J Epidemiol</source><year>2000</year><volume>152</volume><fpage>514</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">10997541</pub-id><pub-id pub-id-type="doi">10.1093/aje/152.6.514</pub-id></citation></ref><ref id="B19"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Vainio</surname><given-names>H</given-names></name><name><surname>Bianchini</surname><given-names>F</given-names></name><collab>(Eds)</collab></person-group><source>Weight Control and Physical Activity</source><year>2002</year><volume>6</volume><publisher-name>Lyons: IARC Press</publisher-name><comment>World Health Organization, International Agency for Research on Cancer: <italic>IARC Handbooks of Cancer Prevention</italic></comment></citation></ref><ref id="B20"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Berglund</surname><given-names>G</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Riboli EL</surname></name></person-group><article-title>Anthropometry, physical activity and cancer of the breast and colon</article-title><source>Nutrition and Lifestyle: Opportunities for Cancer Prevention</source><year>2002</year><publisher-name>Lyons: IARC Scientific Publications</publisher-name><fpage>231</fpage><lpage>241</lpage></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballard-Barbash</surname><given-names>R</given-names></name></person-group><article-title>Anthropometry and breast cancer. Body size &#x02013; a moving target</article-title><source>Cancer</source><year>1994</year><volume>74</volume><issue>3 Suppl</issue><fpage>1090</fpage><lpage>1100</lpage><pub-id pub-id-type="pmid">8039144</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>NB</given-names></name><name><surname>Lyman</surname><given-names>GH</given-names></name><name><surname>Allen</surname><given-names>K</given-names></name><name><surname>Cox</surname><given-names>CE</given-names></name><name><surname>Schapira</surname><given-names>DV</given-names></name></person-group><article-title>Timing of weight gain and breast cancer risk</article-title><source>Cancer</source><year>1995</year><volume>76</volume><fpage>243</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">8625099</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>L</given-names></name><name><surname>Ross</surname><given-names>RK</given-names></name></person-group><article-title>Endogenous hormones and breast cancer risk</article-title><source>Epidemiol Rev</source><year>1993</year><volume>15</volume><fpage>48</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">8405212</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narod</surname><given-names>SA</given-names></name></person-group><article-title>Hormonal prevention of hereditary breast cancer</article-title><source>Ann N Y Acad Sci</source><year>2001</year><volume>952</volume><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">11795442</pub-id></citation></ref><ref id="B25"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Cullinane</surname><given-names>CA</given-names></name><name><surname>Lubinski</surname><given-names>J</given-names></name><name><surname>Neuhausen</surname><given-names>SL</given-names></name><name><surname>Ghadirian</surname><given-names>P</given-names></name><name><surname>Lynch</surname><given-names>HT</given-names></name><name><surname>Isaacs</surname><given-names>C</given-names></name><name><surname>Weber</surname><given-names>B</given-names></name><name><surname>Moller</surname><given-names>P</given-names></name><name><surname>Offit</surname><given-names>K</given-names></name><name><surname>Kim-Sing</surname><given-names>C</given-names></name></person-group><article-title>Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers</article-title><source>Int J Cancer</source><year>2005</year><comment></comment></citation></ref><ref id="B26"><citation citation-type="book"><person-group person-group-type="author"><collab>WHO Expert Committee</collab></person-group><source>Physical Status The Use and Interpretation of Anthropometry</source><year>1995</year><publisher-name>Geneva: World Health Organization</publisher-name></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forbes</surname><given-names>GB</given-names></name><name><surname>Reina</surname><given-names>JC</given-names></name></person-group><article-title>Adult lean body mass declines with age: some longitudinal observations</article-title><source>Metabolism</source><year>1970</year><volume>19</volume><fpage>653</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">5459997</pub-id><pub-id pub-id-type="doi">10.1016/0026-0495(70)90062-4</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>RG</given-names></name></person-group><article-title>Anthropometry and breast cancer</article-title><source>J Nutr</source><year>1997</year><volume>127</volume><issue>5 Suppl</issue><fpage>924S</fpage><lpage>928S</lpage><pub-id pub-id-type="pmid">9164265</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Hankinson</surname><given-names>SE</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Speizer</surname><given-names>FE</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><etal></etal></person-group><article-title>Dual effects of weight and weight gain on breast cancer risk</article-title><source>JAMA</source><year>1997</year><volume>278</volume><fpage>1407</fpage><lpage>1411</lpage><pub-id pub-id-type="pmid">9355998</pub-id><pub-id pub-id-type="doi">10.1001/jama.278.17.1407</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trentham-Dietz</surname><given-names>A</given-names></name><name><surname>Newcomb</surname><given-names>PA</given-names></name><name><surname>Egan</surname><given-names>KM</given-names></name><name><surname>Titmus-Ernstoff</surname><given-names>L</given-names></name><name><surname>Baron</surname><given-names>JA</given-names></name><name><surname>Storer</surname><given-names>BE</given-names></name><name><surname>Stampfer</surname><given-names>M</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>Weight change and risk of postmenopausal breast cancer (United States)</article-title><source>Cancer Causes Control</source><year>2000</year><volume>11</volume><fpage>533</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">10880035</pub-id><pub-id pub-id-type="doi">10.1023/A:1008961931534</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feigelson</surname><given-names>HS</given-names></name><name><surname>Jonas</surname><given-names>CR</given-names></name><name><surname>Teras</surname><given-names>LR</given-names></name><name><surname>Thun</surname><given-names>MJ</given-names></name><name><surname>Calle</surname><given-names>EE</given-names></name></person-group><article-title>Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2004</year><volume>13</volume><fpage>220</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">14973094</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cold</surname><given-names>S</given-names></name><name><surname>Hansen</surname><given-names>S</given-names></name><name><surname>Overvad</surname><given-names>K</given-names></name><name><surname>Rose</surname><given-names>C</given-names></name></person-group><article-title>A woman's build and the risk of breast cancer</article-title><source>Eur J Cancer</source><year>1998</year><volume>34</volume><fpage>1163</fpage><lpage>1174</lpage><pub-id pub-id-type="pmid">9849474</pub-id><pub-id pub-id-type="doi">10.1016/S0959-8049(97)10167-8</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>TS</given-names></name><name><surname>Deffenbaugh</surname><given-names>AM</given-names></name><name><surname>Reid</surname><given-names>JE</given-names></name><name><surname>Hulick</surname><given-names>M</given-names></name><name><surname>Ward</surname><given-names>BE</given-names></name><name><surname>Lingenfelter</surname><given-names>B</given-names></name><name><surname>Gumpper</surname><given-names>KL</given-names></name><name><surname>Scholl</surname><given-names>T</given-names></name><name><surname>Tavtigian</surname><given-names>SV</given-names></name><name><surname>Pruss</surname><given-names>DR</given-names></name><etal></etal></person-group><article-title>Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals</article-title><source>J Clin Oncol</source><year>2002</year><volume>20</volume><fpage>1480</fpage><lpage>1490</lpage><pub-id pub-id-type="pmid">11896095</pub-id><pub-id pub-id-type="doi">10.1200/JCO.20.6.1480</pub-id></citation></ref><ref id="B34"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Hilakivi-Clarke</surname><given-names>LA</given-names></name><name><surname>Luoto</surname><given-names>R</given-names></name><name><surname>Kinnunen</surname><given-names>T</given-names></name><name><surname>Huttunen</surname><given-names>T</given-names></name><name><surname>Gissler</surname><given-names>M</given-names></name><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Hemminki</surname><given-names>E</given-names></name></person-group><article-title>Pregnancy weight gain and mother's breast cancer risk</article-title><source>93rd Annual Meeting of the American Association for Cancer Research, San Francisco, CA</source><year>2002</year></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>WH</given-names></name></person-group><article-title>The changes with age of the anatomical distribution of fat</article-title><source>Soc Sci Med</source><year>1982</year><volume>16</volume><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">6980468</pub-id><pub-id pub-id-type="doi">10.1016/0277-9536(82)90022-3</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>BA</given-names></name></person-group><article-title>Timing of weight gain in relation to breast cancer risk</article-title><source>Ann Oncol</source><year>1995</year><volume>6</volume><fpage>245</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">7612489</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schapira</surname><given-names>DV</given-names></name><name><surname>Kumar</surname><given-names>NB</given-names></name><name><surname>Lyman</surname><given-names>GH</given-names></name><name><surname>Cox</surname><given-names>CE</given-names></name></person-group><article-title>Abdominal obesity and breast cancer risk</article-title><source>Ann Intern Med</source><year>1990</year><volume>112</volume><fpage>182</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">2297194</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang-Claude</surname><given-names>J</given-names></name><name><surname>Becher</surname><given-names>H</given-names></name><name><surname>Eby</surname><given-names>N</given-names></name><name><surname>Gastert</surname><given-names>G</given-names></name><name><surname>Wahrendorf</surname><given-names>J</given-names></name><name><surname>Hamann</surname><given-names>U</given-names></name></person-group><article-title>Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers</article-title><source>J Cancer Res Clin Oncol</source><year>1997</year><volume>123</volume><fpage>272</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">9201250</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirschner</surname><given-names>MA</given-names></name><name><surname>Ertel</surname><given-names>N</given-names></name><name><surname>Schneider</surname><given-names>G</given-names></name></person-group><article-title>Obesity, hormones, and cancer</article-title><source>Cancer Res</source><year>1981</year><volume>41</volume><fpage>3711</fpage><lpage>3717</lpage><pub-id pub-id-type="pmid">7260928</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>KK</given-names></name></person-group><article-title>Obesity as a risk factor for certain types of cancer</article-title><source>Lipids</source><year>1998</year><volume>33</volume><fpage>1055</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">9870899</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potischman</surname><given-names>N</given-names></name><name><surname>Swanson</surname><given-names>CA</given-names></name><name><surname>Siiteri</surname><given-names>P</given-names></name><name><surname>Hoover</surname><given-names>RN</given-names></name></person-group><article-title>Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status</article-title><source>J Natl Cancer Inst</source><year>1996</year><volume>88</volume><fpage>756</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">8637031</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>BE</given-names></name><name><surname>Ross</surname><given-names>RK</given-names></name><name><surname>Judd</surname><given-names>HL</given-names></name><name><surname>Krailo</surname><given-names>MD</given-names></name><name><surname>Pike</surname><given-names>MC</given-names></name></person-group><article-title>Do regular ovulatory cycles increase breast cancer risk?</article-title><source>Cancer</source><year>1985</year><volume>56</volume><fpage>1206</fpage><lpage>1208</lpage><pub-id pub-id-type="pmid">4016708</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pike</surname><given-names>MC</given-names></name><name><surname>Krailo</surname><given-names>MD</given-names></name><name><surname>Henderson</surname><given-names>BE</given-names></name><name><surname>Casagrande</surname><given-names>JT</given-names></name><name><surname>Hoel</surname><given-names>DG</given-names></name></person-group><article-title>'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer</article-title><source>Nature</source><year>1983</year><volume>303</volume><fpage>767</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">6866078</pub-id><pub-id pub-id-type="doi">10.1038/303767a0</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>PC</given-names></name><name><surname>Edman</surname><given-names>CD</given-names></name><name><surname>Hemsell</surname><given-names>DL</given-names></name><name><surname>Porter</surname><given-names>JC</given-names></name><name><surname>Siiteri</surname><given-names>PK</given-names></name></person-group><article-title>Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer</article-title><source>Am J Obstet Gynecol</source><year>1978</year><volume>130</volume><fpage>448</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">629289</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruning</surname><given-names>PF</given-names></name><name><surname>Bonfrer</surname><given-names>JM</given-names></name><name><surname>Hart</surname><given-names>AA</given-names></name></person-group><article-title>Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk</article-title><source>Br J Cancer</source><year>1985</year><volume>51</volume><fpage>479</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">4038881</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaaks</surname><given-names>R</given-names></name></person-group><article-title>Nutrition, hormones, and breast cancer: is insulin the missing link?</article-title><source>Cancer Causes Control</source><year>1996</year><volume>7</volume><fpage>605</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">8932921</pub-id><pub-id pub-id-type="doi">10.1007/BF00051703</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>BA</given-names></name></person-group><article-title>Perimenopausal weight gain and progression of breast cancer precursors</article-title><source>Cancer Detect Prev</source><year>1999</year><volume>23</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9892988</pub-id><pub-id pub-id-type="doi">10.1046/j.1525-1500.1999.00063.x</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Del Giudice</surname><given-names>ME</given-names></name><name><surname>Fantus</surname><given-names>IG</given-names></name><name><surname>Ezzat</surname><given-names>S</given-names></name><name><surname>McKeown-Eyssen</surname><given-names>G</given-names></name><name><surname>Page</surname><given-names>D</given-names></name><name><surname>Goodwin</surname><given-names>PJ</given-names></name></person-group><article-title>Insulin and related factors in premenopausal breast cancer risk</article-title><source>Breast Cancer Res Treat</source><year>1998</year><volume>47</volume><fpage>111</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">9497099</pub-id><pub-id pub-id-type="doi">10.1023/A:1005831013718</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campagnoli</surname><given-names>C</given-names></name><name><surname>Biglia</surname><given-names>N</given-names></name><name><surname>Belforte</surname><given-names>P</given-names></name><name><surname>Botta</surname><given-names>D</given-names></name><name><surname>Pedrini</surname><given-names>E</given-names></name><name><surname>Sismondi</surname><given-names>P</given-names></name></person-group><article-title>Post-menopausal breast cancer risk: oral estrogen treatment and abdominal obesity induce opposite changes in possibly important biological variables</article-title><source>Eur J Gynaecol Oncol</source><year>1992</year><volume>13</volume><fpage>139</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">1587291</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okosun</surname><given-names>IS</given-names></name><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Rotimi</surname><given-names>CN</given-names></name><name><surname>Prewitt</surname><given-names>TE</given-names></name><name><surname>Cooper</surname><given-names>RS</given-names></name></person-group><article-title>Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic Americans</article-title><source>Ann Epidemiol</source><year>2000</year><volume>10</volume><fpage>263</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">10942873</pub-id><pub-id pub-id-type="doi">10.1016/S1047-2797(00)00045-4</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>DJ</given-names></name><name><surname>Hoffmann</surname><given-names>RG</given-names></name><name><surname>Kalkhoff</surname><given-names>RK</given-names></name><name><surname>Kissebah</surname><given-names>AH</given-names></name></person-group><article-title>Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women</article-title><source>J Clin Endocrinol Metab</source><year>1983</year><volume>57</volume><fpage>304</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">6345569</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaye</surname><given-names>SA</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Soler</surname><given-names>JT</given-names></name><name><surname>Prineas</surname><given-names>RJ</given-names></name><name><surname>Potter</surname><given-names>JD</given-names></name></person-group><article-title>Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women</article-title><source>Int J Epidemiol</source><year>1991</year><volume>20</volume><fpage>151</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">2066214</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>DP</given-names></name><name><surname>Gilhooly</surname><given-names>EM</given-names></name><name><surname>Nixon</surname><given-names>DW</given-names></name></person-group><article-title>Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review)</article-title><source>Int J Oncol</source><year>2002</year><volume>21</volume><fpage>1285</fpage><lpage>1292</lpage><pub-id pub-id-type="pmid">12429979</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Juneja</surname><given-names>SC</given-names></name><name><surname>Maihle</surname><given-names>NJ</given-names></name><name><surname>Cleary</surname><given-names>MP</given-names></name></person-group><article-title>Leptin &#x02013; a growth factor in normal and malignant breast cells and for normal mammary gland development</article-title><source>J Natl Cancer Inst</source><year>2002</year><volume>94</volume><fpage>1704</fpage><lpage>1711</lpage><pub-id pub-id-type="pmid">12441326</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verkasalo</surname><given-names>PK</given-names></name><name><surname>Thomas</surname><given-names>HV</given-names></name><name><surname>Appleby</surname><given-names>PN</given-names></name><name><surname>Davey</surname><given-names>GK</given-names></name><name><surname>Key</surname><given-names>TJ</given-names></name></person-group><article-title>Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom)</article-title><source>Cancer Causes Control</source><year>2001</year><volume>12</volume><fpage>47</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">11227925</pub-id><pub-id pub-id-type="doi">10.1023/A:1008929714862</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>JW</given-names></name><name><surname>Key</surname><given-names>TJ</given-names></name><name><surname>Bulbrook</surname><given-names>RD</given-names></name><name><surname>Clark</surname><given-names>GM</given-names></name><name><surname>Allen</surname><given-names>DS</given-names></name><name><surname>Wang</surname><given-names>DY</given-names></name><name><surname>Pike</surname><given-names>MC</given-names></name></person-group><article-title>Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones</article-title><source>Br J Cancer</source><year>1987</year><volume>56</volume><fpage>661</fpage><lpage>666</lpage><pub-id pub-id-type="pmid">3426933</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Renehan</surname><given-names>AG</given-names></name><name><surname>Zwahlen</surname><given-names>M</given-names></name><name><surname>Minder</surname><given-names>C</given-names></name><name><surname>O'Dwyer</surname><given-names>ST</given-names></name><name><surname>Shalet</surname><given-names>SM</given-names></name><name><surname>Egger</surname><given-names>M</given-names></name></person-group><article-title>Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis</article-title><source>Lancet</source><year>2004</year><volume>363</volume><fpage>1346</fpage><lpage>1353</lpage><pub-id pub-id-type="pmid">15110491</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(04)16044-3</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>H</given-names></name><name><surname>LeRoith</surname><given-names>D</given-names></name></person-group><article-title>The role of the insulin-like growth factor system in human cancer</article-title><source>Adv Cancer Res</source><year>1996</year><volume>68</volume><fpage>183</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">8712068</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khandwala</surname><given-names>HM</given-names></name><name><surname>McCutcheon</surname><given-names>IE</given-names></name><name><surname>Flyvbjerg</surname><given-names>A</given-names></name><name><surname>Friend</surname><given-names>KE</given-names></name></person-group><article-title>The effects of insulin-like growth factors on tumorigenesis and neoplastic growth</article-title><source>Endocr Rev</source><year>2000</year><volume>21</volume><fpage>215</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">10857553</pub-id><pub-id pub-id-type="doi">10.1210/er.21.3.215</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Rohan</surname><given-names>T</given-names></name></person-group><article-title>Role of the insulin-like growth factor family in cancer development and progression</article-title><source>J Natl Cancer Inst</source><year>2000</year><volume>92</volume><fpage>1472</fpage><lpage>1489</lpage><pub-id pub-id-type="pmid">10995803</pub-id><pub-id pub-id-type="doi">10.1093/jnci/92.18.1472</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klauwer</surname><given-names>D</given-names></name><name><surname>Blum</surname><given-names>WF</given-names></name><name><surname>Hanitsch</surname><given-names>S</given-names></name><name><surname>Rascher</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>PD</given-names></name><name><surname>Kiess</surname><given-names>W</given-names></name></person-group><article-title>IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: relationship to birthweight, length and gestational age in healthy newborns</article-title><source>Acta Paediatr</source><year>1997</year><volume>86</volume><fpage>826</fpage><lpage>833</lpage><pub-id pub-id-type="pmid">9307161</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogilvy-Stuart</surname><given-names>AL</given-names></name><name><surname>Hands</surname><given-names>SJ</given-names></name><name><surname>Adcock</surname><given-names>CJ</given-names></name><name><surname>Holly</surname><given-names>JM</given-names></name><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Mohamed-Ali</surname><given-names>V</given-names></name><name><surname>Yudkin</surname><given-names>JS</given-names></name><name><surname>Wilkinson</surname><given-names>AR</given-names></name><name><surname>Dunger</surname><given-names>DB</given-names></name></person-group><article-title>Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn</article-title><source>J Clin Endocrinol Metab</source><year>1998</year><volume>83</volume><fpage>3550</fpage><lpage>3557</lpage><pub-id pub-id-type="pmid">9768663</pub-id><pub-id pub-id-type="doi">10.1210/jc.83.10.3550</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juul</surname><given-names>A</given-names></name><name><surname>Bang</surname><given-names>P</given-names></name><name><surname>Hertel</surname><given-names>NT</given-names></name><name><surname>Main</surname><given-names>K</given-names></name><name><surname>Dalgaard</surname><given-names>P</given-names></name><name><surname>Jorgensen</surname><given-names>K</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>K</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name></person-group><article-title>Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index</article-title><source>J Clin Endocrinol Metab</source><year>1994</year><volume>78</volume><fpage>744</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">8126152</pub-id><pub-id pub-id-type="doi">10.1210/jc.78.3.744</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okasha</surname><given-names>M</given-names></name><name><surname>McCarron</surname><given-names>P</given-names></name><name><surname>Gunnell</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name></person-group><article-title>Exposures in childhood, adolescence and early adulthood and breast cancer risk: a systematic review of the literature</article-title><source>Breast Cancer Res Treat</source><year>2003</year><volume>78</volume><fpage>223</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">12725422</pub-id><pub-id pub-id-type="doi">10.1023/A:1022988918755</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><collab>Collaborative Group on Hormonal Factors in Breast Cancer</collab></person-group><article-title>Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease</article-title><source>Lancet</source><year>2001</year><volume>358</volume><fpage>1389</fpage><lpage>1399</lpage><pub-id pub-id-type="pmid">11705483</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(01)06524-2</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stunkard</surname><given-names>AJ</given-names></name><name><surname>Albaum</surname><given-names>JM</given-names></name></person-group><article-title>The accuracy of self-reported weights</article-title><source>Am J Clin Nutr</source><year>1981</year><volume>34</volume><fpage>1593</fpage><lpage>1599</lpage><pub-id pub-id-type="pmid">7270483</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>TW</given-names></name><name><surname>Kushi</surname><given-names>LH</given-names></name><name><surname>McGovern</surname><given-names>PG</given-names></name><name><surname>Potter</surname><given-names>JD</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>King</surname><given-names>RA</given-names></name><name><surname>Whitbeck</surname><given-names>J</given-names></name><name><surname>Greenstein</surname><given-names>J</given-names></name><name><surname>Steller</surname><given-names>TA</given-names></name></person-group><article-title>Validation study of self-reported measures of fat distribution</article-title><source>Int J Obes Relat Metab Disord</source><year>1996</year><volume>20</volume><fpage>644</fpage><lpage>650</lpage><pub-id pub-id-type="pmid">8817358</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Chute</surname><given-names>CG</given-names></name><name><surname>Litin</surname><given-names>LB</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>Validity of self-reported waist and hip circumferences in men and women</article-title><source>Epidemiology</source><year>1990</year><volume>1</volume><fpage>466</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">2090285</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Troy</surname><given-names>LM</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>The validity of recalled weight among younger women</article-title><source>Int J Obes Relat Metab Disord</source><year>1995</year><volume>19</volume><fpage>570</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">7489028</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Must</surname><given-names>A</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Dietz</surname><given-names>WH</given-names></name></person-group><article-title>Remote recall of childhood height, weight, and body build by elderly subjects</article-title><source>Am J Epidemiol</source><year>1993</year><volume>138</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">8333427</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>J</given-names></name><name><surname>Keil</surname><given-names>JE</given-names></name><name><surname>Waid</surname><given-names>LR</given-names></name><name><surname>Gazes</surname><given-names>PC</given-names></name></person-group><article-title>Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population</article-title><source>Am J Epidemiol</source><year>1990</year><volume>132</volume><fpage>1156</fpage><lpage>1163</lpage><pub-id pub-id-type="pmid">2260547</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>VA</given-names></name><name><surname>Dwyer</surname><given-names>JT</given-names></name><name><surname>Coleman</surname><given-names>KA</given-names></name><name><surname>Krall</surname><given-names>EA</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Valadian</surname><given-names>I</given-names></name></person-group><article-title>Accuracy of recall by middle-aged participants in a longitudinal study of their body size and indices of maturation earlier in life</article-title><source>Ann Hum Biol</source><year>1991</year><volume>18</volume><fpage>155</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">2024949</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Weight at various ages among <italic>BRCA </italic>mutation carriers according to year of birth.</p></caption><graphic xlink:href="bcr1293-1"></graphic></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Comparison of subjects carrying <italic>BRCA </italic>mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Variable</td><td align="center">Control subjects (<italic>n </italic>= 1,073)</td><td align="center">Case subjects (<italic>n </italic>= 1,073)</td><td align="center"><italic>P</italic><sup>a</sup></td></tr></thead><tbody><tr><td align="left">Age (years) at interview, no. (%)</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02264; 30</td><td align="center">17 (1.6)</td><td align="center">26 (2.4)</td><td></td></tr><tr><td align="left">&#x02003;31&#x02013;40</td><td align="center">219 (20.4)</td><td align="center">242 (22.5)</td><td></td></tr><tr><td align="left">&#x02003;41&#x02013;50</td><td align="center">415 (38.7)</td><td align="center">386 (36.0)</td><td></td></tr><tr><td align="left">&#x02003;51&#x02013;60</td><td align="center">277 (25.8)</td><td align="center">264 (24.6)</td><td></td></tr><tr><td align="left">&#x02003;&#x02265; 61</td><td align="center">145 (13.5)</td><td align="center">155 (14.5)</td><td align="center">0.32</td></tr><tr><td align="left">Age (years) at interview, mean (SD)</td><td align="center">47.9 (10.6)</td><td align="center">48.6 (10.6)</td><td align="center">0.25</td></tr><tr><td align="left">Date of birth, mean year</td><td align="center">1951.8</td><td align="center">1951.2</td><td align="center">0.14</td></tr><tr><td align="left">Year of interview, mean (range)</td><td align="center">1999.7 (1995&#x02013;2004)</td><td align="center">1999.8 (1999&#x02013;2004)</td><td align="center">0.18</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td align="left">Age (years) at diagnosis of breast cancer, no. (%)</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02264; 30</td><td align="center">NA</td><td align="center">107 (10.0)</td><td></td></tr><tr><td align="left">&#x02003;31&#x02013;40</td><td></td><td align="center">478 (44.5)</td><td></td></tr><tr><td align="left">&#x02003;41&#x02013;50</td><td></td><td align="center">371 (34.5)</td><td></td></tr><tr><td align="left">&#x02003;&#x02265; 51</td><td></td><td align="center">117 (10.9)</td><td></td></tr><tr><td align="left">Age (years) at diagnosis of breast cancer, mean (SD)</td><td></td><td align="center">39.8 (8.3)</td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td align="left">Mutation, %</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;<italic>BRCA1</italic></td><td align="center">74.3</td><td align="center">74.3</td><td></td></tr><tr><td align="left">&#x02003;<italic>BRCA2</italic></td><td align="center">25.7</td><td align="center">25.7</td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td align="left">Parity</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;No. (%) parous</td><td align="center">844 (79.6)</td><td align="center">879 (82.8)</td><td align="center">0.06</td></tr><tr><td align="left">&#x02003;Parity, mean (SD)</td><td align="center">1.9 (1.4)</td><td align="center">1.9 (1.3)</td><td align="center">0.18</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td align="left">No. (%) who ever used oral contraceptives</td><td align="center">662 (62.6)</td><td align="center">710 (66.8)</td><td align="center">0.04</td></tr><tr><td align="left">No. (%) who ever smoked</td><td align="center">465 (43.3)</td><td align="center">471 (43.9)</td><td align="center">0.79</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Country of residence at time of testing, no. (%)</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Canada</td><td align="center">420 (39.1)</td><td align="center">420 (39.1)</td><td></td></tr><tr><td align="left">&#x02003;Israel</td><td align="center">20 (1.9)</td><td align="center">20 (1.9)</td><td></td></tr><tr><td align="left">&#x02003;UK</td><td align="center">8 (0.8)</td><td align="center">8 (0.8)</td><td></td></tr><tr><td align="left">&#x02003;Poland</td><td align="center">189 (17.6)</td><td align="center">189 (17.6)</td><td></td></tr><tr><td align="left">&#x02003;USA</td><td align="center">436 (40.6)</td><td align="center">436 (40.6)</td><td></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>All <italic>P </italic>values are univariate and were derived using Student's <italic>t</italic>-test for continuous variables and the &#x003c7;<sup>2 </sup>test for categorical variables. NA, not applicable; SD, standard deviation.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Anthropometric variables in women with a deleterious <italic>BRCA1 </italic>or <italic>BRCA2 </italic>mutation<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="3">All</td><td align="center" colspan="3">Premenopausal</td><td align="center" colspan="3">Postmenopausal</td></tr><tr><td align="left">Variable</td><td align="center">Cases <italic> n </italic>= 1073</td><td align="center">Controls <italic>n </italic>= 1073</td><td align="center"><italic>P</italic></td><td align="center">Cases <italic>n </italic>= 817</td><td align="center">Controls <italic>n </italic>= 817</td><td align="center"><italic>P</italic></td><td align="center">Cases <italic>n </italic>= 256</td><td align="center">Controls <italic>n </italic>= 256</td><td align="center"><italic>P</italic></td></tr></thead><tbody><tr><td align="left">Weight (pounds)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;At birth</td><td align="center">7.1 (1.3)</td><td align="center">7.1 (1.3)</td><td align="center">0.67</td><td align="center">NA</td><td align="center">NA</td><td align="center">NA</td><td align="center">NA</td><td align="center">NA</td><td align="center">NA</td></tr><tr><td align="left">&#x02003;At age 18</td><td align="center">120.6 (17.2)</td><td align="center">122.3 (19.1)</td><td align="center">0.03</td><td align="center">121.5 (17.1)</td><td align="center">122.9 (19.2)</td><td align="center">0.11</td><td align="center">117.8 (17.3)</td><td align="center">120.4 (18.5)</td><td align="center">0.10</td></tr><tr><td align="left">&#x02003;At age 30<sup>c</sup></td><td align="center">130.9 (17.3)</td><td align="center">131.2 (18.5)</td><td align="center">0.75</td><td align="center">131.9 (17.1)</td><td align="center">132.2 (18.5)</td><td align="center">0.87</td><td align="center">127.9 (17.4)</td><td align="center">128.6 (18.6)</td><td align="center">0.69</td></tr><tr><td align="left">&#x02003;At age 40<sup>d</sup></td><td align="center">137.7 (23.4)</td><td align="center">137.7 (24.3)</td><td align="center">0.99</td><td align="center">139.7 (22.8)</td><td align="center">138.7 (25.0)</td><td align="center">0.63</td><td align="center">135.3 (23.9)</td><td align="center">136.5 (23.4)</td><td align="center">0.59</td></tr><tr><td align="left">Current height (inches)</td><td align="center">64.2 (2.6)</td><td align="center">64.3 (2.6)</td><td align="center">0.44</td><td align="center">64.3 (2.6)</td><td align="center">64.5 &#x000b1; 2.6</td><td align="center">0.50</td><td align="center">63.9 &#x000b1; 2.7</td><td align="center">63.7 &#x000b1; 2.7</td><td align="center">0.10</td></tr><tr><td align="left">Body mass index<sup>b</sup></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;At age 18 (kg/m<sup>2</sup>)</td><td align="center">20.57 (2.8)</td><td align="center">20.77 (3.0)</td><td align="center">0.10</td><td align="center">20.65 (2.8)</td><td align="center">20.74 (3.0)</td><td align="center">0.52</td><td align="center">20.31 (2.7)</td><td align="center">20.88 (2.9)</td><td align="center">0.03</td></tr><tr><td align="left">&#x02003;At age 30 (kg/m<sup>2</sup>)<sup>c</sup></td><td align="center">22.35 (3.4)</td><td align="center">22.32 (3.7)</td><td align="center">0.88</td><td align="center">22.44 (3.4)</td><td align="center">22.33 (3.9)</td><td align="center">0.56</td><td align="center">22.08 (3.4)</td><td align="center">22.31 (3.1)</td><td align="center">0.43</td></tr><tr><td align="left">&#x02003;At age 40 (kg/m<sup>2</sup>)<sup>d</sup></td><td align="center">23.77 (3.9)</td><td align="center">23.73 (3.9)</td><td align="center">0.88</td><td align="center">24.06 (3.8)</td><td align="center">23.67 (4.1)</td><td align="center">0.26</td><td align="center">23.42 (4.0)</td><td align="center">23.80 (3.7)</td><td align="center">0.29</td></tr><tr><td align="left">Weight gain (pounds)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;From age 18 to 30<sup>c</sup></td><td align="center">10.5 (15.2)</td><td align="center">9.4 (17.0)</td><td align="center">0.14</td><td align="center">10.6 (15.1)</td><td align="center">9.8 (18.2)</td><td align="center">0.35</td><td align="center">10.1 (15.7)</td><td align="center">8.2 (13.0)</td><td align="center">0.23</td></tr><tr><td align="left">&#x02003;From age 30 to 40<sup>d</sup></td><td align="center">9.4 (12.5)</td><td align="center">9.2 (13.3)</td><td align="center">0.82</td><td align="center">10.6 (12.5)</td><td align="center">9.1 (15.3)</td><td align="center">0.23</td><td align="center">7.9 (12.3)</td><td align="center">8.2 (10.5)</td><td align="center">0.23</td></tr><tr><td align="left">&#x02003;From age 18 to 40<sup>d</sup></td><td align="center">18.6 (19.5)</td><td align="center">18.1 (20.4)</td><td align="center">0.71</td><td align="center">19.9 (20.2)</td><td align="center">19.0 (22.1)</td><td align="center">0.61</td><td align="center">17.0 (18.6)</td><td align="center">17.1 (18.2)</td><td align="center">0.98</td></tr></tbody></table><table-wrap-foot><p>The subjects were women who did (case subjects) or did not (control subjects) have a diagnosis of invasive breast cancer. <sup>a</sup><italic>P </italic>values are univariate and were derived using Student's <italic>t</italic>-test and include both <italic>BRCA1 </italic>and <italic>BRCA2 </italic>mutation carriers. Other values are means (standard deviations). <sup>b</sup>Excludes subjects with missing data on current height. <sup>c</sup>Calculated for pairs in which case subjects were diagnosed at age &#x0003e;30 years. <sup>d</sup>Calculated for pairs in which case subjects were diagnosed at age &#x0003e;40 years. NA, not applicable.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Weight change and subsequent cancer risk: subjects stratified by their age at diagnosis of cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Weight change between age 18 and 30 years</td><td align="center">Cases (number)</td><td align="center">Controls (number)</td><td align="center">OR<sup>a </sup>(95% CI)</td><td align="center"><italic>P</italic></td><td align="center"><italic>P </italic>for trend</td></tr></thead><tbody><tr><td align="left">In all subjects<sup>b</sup></td><td align="center">966</td><td align="center">966</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Loss of at least 10 pounds</td><td align="center">53</td><td align="center">81</td><td align="center">0.66 (0.46&#x02013;0.93)</td><td align="center">0.03</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Loss of &#x0003c;10 to gain of &#x02264; 10 pounds</td><td align="center">536</td><td align="center">542</td><td align="center">1 (referent)</td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Gain of 10 to &#x02264; 20 pounds</td><td align="center">227</td><td align="center">190</td><td align="center">1.19 (0.96&#x02013;1.49)</td><td align="center">0.12</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Gain of &#x0003e; 20 pounds</td><td align="center">150</td><td align="center">135</td><td align="center">1.00 (0.77&#x02013;1.30)</td><td align="center">0.99</td><td align="center">0.46</td></tr><tr><td align="left">According to case subjects' age at diagnosis</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x0003e;30 to &#x02264; 40 years<sup>c</sup></td><td align="center">478</td><td align="center">478</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Loss of at least 10 pounds</td><td align="center">23</td><td align="center">49</td><td align="center">0.47 (0.28&#x02013;0.79)</td><td align="center">0.005</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Loss of &#x0003c;10 to gain of &#x02264; 10 pounds<sup>d</sup></td><td align="center">255</td><td align="center">254</td><td align="center">1 (referent)</td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Gain of 10 to &#x02264; 20 pounds</td><td align="center">112</td><td align="center">89</td><td align="center">1.25 (0.91&#x02013;1.71)</td><td align="center">0.17</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Gain of &#x0003e;20 pounds</td><td align="center">88</td><td align="center">86</td><td align="center">1.03 (0.72&#x02013;1.47)</td><td align="center">0.88</td><td align="center">0.48</td></tr><tr><td align="left">&#x02003;&#x0003e;40 years<sup>d</sup></td><td align="center">488</td><td align="center">488</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Loss of at least 10 pounds</td><td align="center">30</td><td align="center">32</td><td align="center">0.97 (0.52&#x02013;1.65)</td><td align="center">0.91</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Loss of &#x0003c;10 to gain of &#x02264; 10 pounds<sup>d</sup></td><td align="center">281</td><td align="center">288</td><td align="center">1 (referent)</td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Gain of 10 to &#x02264; 20 pounds</td><td align="center">115</td><td align="center">101</td><td align="center">1.16 (0.85&#x02013;1.59)</td><td align="center">0.36</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Gain of &#x0003e;20 pounds</td><td align="center">62</td><td align="center">67</td><td align="center">0.95 (0.64&#x02013;1.43)</td><td align="center">0.82</td><td align="center">0.75</td></tr></tbody></table><table-wrap-foot><p>Subjects were women with a deleterious mutation in <italic>BRCA1 </italic>or <italic>BRCA2 </italic>who did (case subjects) or did not (control subjects) receive a diagnosis of cancer. <sup>a</sup>All odds ratios (ORs) were derived using univariate conditional logistic regression. <sup>b</sup>Excludes case subjects diagnosed at age &#x02264; 30 years. <sup>c</sup>Excludes case subjects diagnosed at age &#x02264; 30 and &#x0003e;40 years. <sup>d</sup>Excludes case subjects diagnosed at &#x02264; 40 years. CI, confidence interval.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Weight change and subsequent cancer risk: subjects stratified by their <italic>BRCA </italic>mutation</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Weight change between age 18 and 30 years</td><td align="center">Cases (n)</td><td align="center">Controls (n)</td><td align="center">OR<sup>a </sup>(95% CI)</td><td align="center"><italic>P</italic></td><td align="center"><italic>P </italic>for trend</td></tr></thead><tbody><tr><td align="left">In <italic>BRCA1 </italic>mutation carriers</td><td align="center">370</td><td align="center">370</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Loss of at least 10 pounds</td><td align="center">13</td><td align="center">38</td><td align="center">0.35 (0.18&#x02013;0.67)</td><td align="center">0.002</td><td></td></tr><tr><td align="left">&#x02003;Loss of &#x0003c;10 to gain of &#x02264; 10 pounds<sup>d</sup></td><td align="center">188</td><td align="center">189</td><td align="center">1 (referent)</td><td></td><td></td></tr><tr><td align="left">&#x02003;Gain of 10 to &#x02264; 20 pounds</td><td align="center">93</td><td align="center">72</td><td align="center">1.29 (0.91&#x02013;1.83)</td><td align="center">0.15</td><td></td></tr><tr><td align="left">&#x02003;Gain of &#x0003e;20 pounds</td><td align="center">76</td><td align="center">71</td><td align="center">1.09 (0.73&#x02013;1.62)</td><td align="center">0.67</td><td align="center">0.34</td></tr><tr><td align="left">In <italic>BRCA2 </italic>mutation carriers</td><td align="center">108</td><td align="center">108</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Loss of at least 10 pounds</td><td align="center">10</td><td align="center">11</td><td align="center">0.88 (0.35&#x02013;2.23)</td><td align="center">0.78</td><td></td></tr><tr><td align="left">&#x02003;Loss of &#x0003c;10 to gain of &#x02264; 10 pounds<sup>d</sup></td><td align="center">67</td><td align="center">65</td><td align="center">1 (referent)</td><td></td><td></td></tr><tr><td align="left">&#x02003;Gain of 10 to &#x02264; 20 pounds</td><td align="center">19</td><td align="center">17</td><td align="center">1.08 (0.50&#x02013;2.35)</td><td align="center">0.84</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Gain of &#x0003e;20 pounds</td><td align="center">12</td><td align="center">15</td><td align="center">0.77 (0.33&#x02013;1.81)</td><td align="center">0.55</td><td align="center">0.70</td></tr></tbody></table><table-wrap-foot><p>Subjects were women with a deleterious mutation in <italic>BRCA1 </italic>or <italic>BRCA2 </italic>who did (case subjects) or did not (matched control subjects) receive a diagnosis of breast cancer at age 30 to 39 years. <sup>a</sup>All odds ratios (ORs) were derived using univariate conditional logistic regression. CI, confidence interval.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Weight change and subsequent cancer risk: subjects<sup>a </sup>stratified by <italic>BRCA </italic>mutation and parity</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Weight change between age 18 and 30 years</td><td align="center">Cases (number)</td><td align="center">Controls (number)</td><td align="center">OR<sup>c </sup>(95% CI)</td><td align="center"><italic>P</italic></td><td align="center"><italic>P </italic>for trend<sup>d</sup></td></tr></thead><tbody><tr><td align="left">In <italic>BRCA1 </italic>mutation carriers</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Loss of &#x0003c;10 to gain of &#x02264; 10 pounds<sup>b</sup></td><td align="center">188</td><td align="center">189</td><td align="center">1 (referent)</td><td></td><td></td></tr><tr><td align="left">&#x02003;Gain of &#x0003e;10 pounds</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Parity = 0</td><td align="center">24</td><td align="center">28</td><td align="center">0.88 (0.50&#x02013;1.55)</td><td align="center">0.66</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Parity = 1</td><td align="center">26</td><td align="center">27</td><td align="center">0.94 (0.52&#x02013;1.72)</td><td align="center">0.85</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Parity &#x02265; 2</td><td align="center">117</td><td align="center">84</td><td align="center">1.44 (1.01&#x02013;2.04)</td><td align="center">0.04</td><td align="center">0.16</td></tr><tr><td align="left">&#x02003;&#x02003;Parity unknown</td><td align="center">2</td><td align="center">4</td><td></td><td></td><td></td></tr><tr><td align="left">In <italic>BRCA2 </italic>mutation carriers</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Loss of &#x0003c;10 to gain of &#x02264; 10 pounds<sup>b</sup></td><td align="center">67</td><td align="center">65</td><td align="center">1 (referent)</td><td></td><td></td></tr><tr><td align="left">&#x02003;Gain of &#x0003e;10 pounds</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Parity = 0</td><td align="center">6</td><td align="center">4</td><td align="center">1.44 (0.40&#x02013;5.13)</td><td align="center">0.58</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Parity = 1</td><td align="center">7</td><td align="center">6</td><td align="center">1.10 (0.33&#x02013;3.72)</td><td align="center">0.87</td><td></td></tr><tr><td align="left">&#x02003;&#x02003;Parity &#x02265; 2</td><td align="center">18</td><td align="center">22</td><td align="center">0.73 (0.33&#x02013;1.64)</td><td align="center">0.45</td><td align="center">0.31</td></tr><tr><td align="left">&#x02003;&#x02003;Parity unknown</td><td align="center">0</td><td align="center">0</td><td></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Whose cancer was diagnosed when they were 30 to 39 years old. <sup>b</sup>A negative number indicates weight loss. <sup>c</sup>All ORs were derived using univariate conditional logistic regression. <sup>d</sup>Excludes subjects in the weight-gain &#x02264; -10 group.</p></table-wrap-foot></table-wrap></sec></back></article> 